Sfoglia per Autore
Toll-deficient Drosophila are resistant to infection by Pneumocystis spp. Additional evidence of specificity to mammalian hosts
2010 S. E. Evans;K. Leventakos;R. Ben-Ami;D. You;S. G. Thakkar;R. E. Lewis;D. P. Kontoyiannis
Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis
2010 M. A. Milito;D. P. Kontoyiannis;R. E. Lewis;P. Liu;O. R. Mawlaw;M. T. Truong;E. M. Marom
Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection
2010 R. Ben-Ami;R. E. Lewis;D. P. Kontoyiannis
Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection
2011 R. E. Lewis;G. Liao;W. Wang;R. A. Prince;D. P. Kontoyiannis
Pharmacokinetic-pharmacodynamic optimization of triazole antifungal therapy
2011 R. E. Lewis
Efficacy of Caspofungin in Neutropenic and Corticosteroid-Immunosuppressed Murine Models of Invasive Pulmonary Mucormycosis
2011 R. E. Lewis;K. Leventakos;G. Liao;D. P. Kontoyiannis
Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species
2011 S. C. .;R. E. Lewis;D. P. Kontoyiannis
In vitro interactions among echinocandins against Aspergillus fumigatus: lack of concordance among methods
2011 R. Ben-Ami;R. E. Lewis;D. P. Kontoyiannis
Fungal Drug Resistance and Pharmacologic Considerations of Dosing Newer Antifungal Therapies
2011 Lewis; Perlin David S.
How I treat mucormycosis
2011 D. P. Kontoyiannis;R. E. Lewis
Current Concepts in Antifungal Pharmacology
2011 R. E. Lewis
Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus
2011 R. E. Lewis;G. Liao;J. Hou;R. A. Prince;D. P. Kontoyiannis
Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance
2011 R. Ben-Ami;G. Garcia-Effron;R. E. Lewis;S. Gamarra;K. Leventakos;D. S. Perlin;D. P. Kontoyiannis
Activity of Deferasirox in Mucorales: Influences of Species and Exogenous Iron
2011 R. E. Lewis;G. N. Pongas;N. Albert;R. Ben-Ami;T. J. Walsh;D. P. Kontoyiannis
Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species
2011 M. Z. R.;R. E. Lewis;D. P. Kontoyiannis
Combination Therapy for Mucormycosis: Why, What, and How?
2012 B. Spellberg;A. Ibrahim;E. Roilides;R. E. Lewis;O. Lortholary;G. Petrikkos;D. P. Kontoyiannis;T. J. Walsh
Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies
2012 L. Cahuayme-Zuniga;R. E. Lewis;V. E. Mulanovich;D. P. Kontoyiannis
Importance of Pharmacokinetic Considerations for Selecting Therapy in the Treatment of Invasive Fungal Infections
2012 R. E. Lewis
The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida.
2012 Lewis RE; Viale P; Kontoyiannis DP
Echinocandin Resistance in Candida Species: Mechanisms of Reduced Susceptibility and Therapeutic Approaches
2012 N. D. Beyda;R. E. Lewis;K. W. Garey
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile